At the World Peace Forum on 4 July 2026, Ambassador Vikram Doraiswami urged deeper Chinese investment in India and highlighted the need to boost Indian exports, especially in the pharmaceutical sector.
Key Developments
- India wants to increase Chinese investment in strategic areas.
- Push for Indian generic medicines, already sold to the U.S., to enter the Chinese market.
- Recognition that trade has grown despite a political freeze since the 2020 LAC standoff.
- Call for consumer‑protection mechanisms that allow India to export higher‑value goods while managing the large trade gap.
Important Facts
In FY 2025‑26, China was India’s largest trading partner with total bilateral trade of $151.1 billion. The deficit stood at $112.16 billion. India’s imports from China are dominated by electrical machinery, finished goods and intermediate inputs, while exports remain modest.
Since March 2026, India has relaxed the restrictions imposed in early 2020, allowing more Chinese capital under the revised Press Note 3. The government has signalled willingness to “hand‑hold” Chinese firms, especially in sectors such as chemicals, renewable‑energy components and other inputs critical for value‑added manufacturing.
Exam Relevance
This development touches on several GS papers. GS 2 (Polity & International Relations) requires understanding of India‑China diplomatic dynamics, the role of ambassadors, and the strategic significance of the